Arnold J. Levine's most recent trade in PMV Pharmaceuticals Inc was a trade of 33,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 33,500 | 33,500 | - | - | Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 67,500 | 67,500 | - | - | Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 21,500 | 21,500 | - | - | Stock Option (right to buy) | |
MeiraGTx Holdings plc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Restricted Share Units | |
MeiraGTx Holdings plc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 19,500 | 19,500 | - | - | Stock option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 22 Sep 2021 | 3,500 | 409,842 | - | 30 | 105,000 | Common Stock |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 29.50 per share. | 23 Aug 2021 | 3,500 | 413,342 | - | 29.5 | 103,250 | Common Stock |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 33.22 per share. | 21 Jun 2021 | 3,389 | 420,453 | - | 33.2 | 112,579 | Common Stock |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 21 Jun 2021 | 111 | 420,342 | - | 34.1 | 3,783 | Common Stock |
MeiraGTx Holdings plc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Restricted Share Units | |
MeiraGTx Holdings plc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 16,333 | 16,333 | - | - | Stock option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 34.68 per share. | 20 May 2021 | 2,961 | 423,842 | - | 34.7 | 102,676 | Common Stock |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 33.57 per share. | 20 May 2021 | 539 | 426,803 | - | 33.6 | 18,092 | Common Stock |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,781 | 5,781 | - | - | Stock Option (right to buy) | |
PMV Pharmaceuticals Inc | Arnold J. Levine | Director | Sale of securities on an exchange or to another person at price $ 35.12 per share. | 12 May 2021 | 3,500 | 416,842 | - | 35.1 | 122,929 | Common Stock |